Search Results 141-150 of 16256 for monoclonal antibody
About this study. The purpose of this study is to evaluate the safety and tolerability of the combination of idelallisib with the monoclonal antibody BI ...
Dinutuximab is a monoclonal antibody that binds to a molecule called GD2, which is found in greater than normal amounts on some types of cancer cells. This ...
Of those monoclonal antibody infusions, 16,000 were administered in the Midwest, including 10,000 in rural communities throughout southern Minnesota and western ...
Rituximab-abbs is a monoclonal antibody. Rituximab-abbs injection is used together with other cancer medicines (eg, fludarabine and cyclophosphamide) to ...
A monoclonal antibody, lecanemab, shows promise in removing amyloid plaques from the brain, according to phase 3 trial results. Amyloid plaques are one of ...
Monoclonal antibody, such as rituximab, may block cancer growth in different ways by targeting certain cells. It is not yet known whether combination ...
These previous treatments include a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 monoclonal antibody. This medicine is available only ...
Monoclonal antibodies, such as varlilumab and nivolumab, may work by ... History of severe hypersensitivity reaction to any monoclonal antibody.
Duvelisib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as nivolumab ...
Certain medicines, such as monoclonal antibodies and medicines to suppress the immune system after a transplant. Autoimmune encephalitis is more likely to ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Benefactor support fuels Mayo Clinic’s groundbreaking research. Make a gift today to help us save lives.